Trudel, S., Beksac, M., Pour, L., Delimpasi, S., Vorobyev, V., Quach, H., Špička, I., Radocha, J., Robak, P., Kim, K., Cavo, M., Suzuki, K., Zafar, S., Moore, A., Duggan, M., Morris, K., Phillips-Jones, A., Polinkovsky, M., Grams, J., Garrobo-Calleja, I., Manasanch, E., Kremer, B., Opalinska, J., Mateos, M., Dimopoulos, M. (2025). Deep responses and durable outcomes in patients treated with belantamab mafodotin plus pomalidomide and dexamethasone from long-term follow-up of the Phase 3 dreamm-8 study. Blood. https://doi.org/10.1182/blood-2025-2264